|
|
|
Prosonix and Aeropharm Announce Agreement |
 |
 |
 |
|
Written by Graham Ruecroft
|
|
Friday, 19 December 2008 12:35 |
 Prosonix Ltd (Oxford, UK) is delighted to announce a new agreement for the application of its proprietary ultrasonic particle engineering technology in the pharmaceutical industry. This new agreement has been concluded with Aeropharm (Rudolstadt, Germany) and is concerned with the development and manufacture of a new generation of "difficult-to-make" generic products.
|
|
Last Updated on Tuesday, 03 February 2009 22:14 |
|
KTP Research Funding For Prosonix and Bath University |
|
|
|
|
Written by Graham Ruecroft
|
|
Friday, 08 May 2009 17:00 |
 Prosonix will be recruiting a high quality researcher in light of the recent announce -ment that a research grant of £190,500 has been awarded to the Department of Pharmacy and Pharmacology and Prosonix to develop methodology and identify new processing technology for the manufacture of pharmaceutical co-crystals and binary API crystals suitable for use in inhaled and oral medicines.
|
|
Last Updated on Saturday, 09 May 2009 18:30 |
|
|
Pfizer Selects Prosonix Crystallization Technology |
|
|
|
|
Written by Christian Jones
|
|
Friday, 19 December 2008 11:47 |
 Prosonix Ltd (Oxford, UK) is delighted to announce that Pfizer Global Manufacturing will implement Prosonix’ Prosonitron reactor and sonocrystallization process technology at Pfizer’s manufacturing facilities in Ireland.
|
|
Last Updated on Tuesday, 03 February 2009 22:15 |
|
Prosonix Featured in Pharmaceutical Technology |
|
|
|
|
Written by Graham Ruecroft
|
|
Friday, 19 December 2008 11:48 |
|
|
|
Last Updated on Saturday, 31 January 2009 15:51 |
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
|
|
Page 3 of 9 |
Meet David Hipkiss (CEO) and Christian Jones of Prosonix at InformexUSA, scheduled at the Moscone Center West in San Fransisco, January 27-30 2009. As the premier networking event for the chemical industry in the United States, InformexUSA is designed to showcase the chemistry capabilities of high-value, high-quality businesses.
Prosonix describe their latest advanced ultrasonic particle engineering developments in a feature article entitled "Power Ultrasound and the Production of Mesoscopic Particles and Aqueous Dispersions". For full details visit www.pharmtech.com, or read the special supplement pages s28-s35 accompanying the September 2008, Volume 32, 9 edition of Pharmaceutical Technology.